首页|氯吡格雷联合阿司匹林治疗老年冠心病的临床疗效分析

氯吡格雷联合阿司匹林治疗老年冠心病的临床疗效分析

扫码查看
目的 分析氯吡格雷联合阿司匹林治疗老年冠心病的效果。方法 60 例老年冠心病患者纳入此次研究,随机分为研究组与常规组,每组 30 例。常规组患者实施阿司匹林治疗,研究组患者实施氯吡格雷联合阿司匹林治疗。对比两组治疗效果、炎症指标[白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)以及超敏C反应蛋白(hs-CRP)]、凝血功能[凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(Fbg)]、不良反应发生情况。结果 研究组患者治疗总有效率 93。33%显著高于常规组的 73。33%,差异显著(P<0。05)。治疗前,两组IL-6、TNF-α、hs-CRP对比差异无统计学意义(P>0。05);治疗后,研究组患者IL-6(34。15±3。14)pg/ml、TNF-α(103。23±18。40)pg/ml、hs-CRP(7。53±1。35)mg/L较常规组的(43。71±3。56)pg/ml、(137。88±20。41)pg/ml、(9。54±1。81)mg/L更优,差异显著(P<0。05)。治疗前,两组APTT、PT、Fbg对比差异无统计学意义(P>0。05);治疗后,研究组APTT(33。19±2。03)s、PT(13。14±1。36)s、Fbg(2。12±0。85)g/L均优于常规组的(30。89±3。11)s、(11。58±2。47)s、(3。11±1。02)g/L,差异显著(P<0。05)。研究组不良反应发生率 10。00%低于常规组的 33。33%,差异显著(P<0。05)。结论 氯吡格雷联合阿司匹林在老年冠心病患者治疗中,其效果十分显著。
Clinical efficacy analysis of clopidogrel combined with aspirin in the treatment of coronary heart disease in the elderly
Objective To analyze the effect of clopidogrel combined with aspirin in the treatment of coronary heart disease in the elderly.Methods A total of 60 elderly patients with coronary heart disease were included and randomly divided into a study group and a conventional group,with 30 cases in each group.The study group received clopidogrel combined with aspirin treatment,while the conventional group received aspirin treatment.Both groups were compared in terms of treatment effects,inflammatory markers[interleukin-6(IL-6),tumor necrosis factor-α(TNF-α)and hypersensitive C-reactive protein(hs-CRP)],coagulation function[prothrombin time(PT),activated partial thromboplastin time(APTT),fibrinogen(Fbg)],and adverse reactions.Results The total effective rate of 93.33%in the study group was significantly higher than 73.33%in the conventional group,and the difference was significant(P<0.05).Before treatment,there was no significant difference in IL-6,TNF-α and hs-CRP between the two groups(P>0.05).After treatment,the study group had IL-6 of(34.15±3.14)pg/ml,TNF-α of(103.23±18.40)pg/ml and hs-CRP of(7.53±1.35)mg/L,which were higher than(43.71±3.56)pg/ml,(137.88±20.41)pg/ml and(9.54±1.81)mg/L in the conventional group,and the difference was significant(P<0.05).Before treatment,there was no significant difference in APTT,PT and Fbg between the two groups(P>0.05).After treatment,the study group had APTT of(33.19±2.03)s,PT of(13.14±1.36)s and Fbg of(2.12±0.85)g/L,which were better than(30.89±3.11)s,(11.58±2.47)s and(3.11±1.02)g/L in the conventional group.The difference was significant(P<0.05).The incidence of adverse reactions in the study group was 10.00%,which was lower than 33.33%in the conventional group,and the difference was significant(P<0.05).Conclusion Clopidogrel combined with aspirin is effective in the treatment of elderly patients with coronary heart disease.

ClopidogrelAspirinCoronary heart disease in the elderlyClinical efficacy

赵中伟

展开 >

276500 山东省日照市莒县人民医院

氯吡格雷 阿司匹林 老年冠心病 临床疗效

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(6)
  • 12